Tag - ABCL

Developments

Confo, AbCellera in GPCR-targeting antibody discovery program

Confo Therapeutics of Belgium entered into a research collaboration with AbCellera Biologics (NASDAQ:ABCL) for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets (G protein-coupled...

June 15, 2023

Developments

AbCellera Biologics CEO Carl Hansen wins 2021 Bloom Burton Award

AbCellera Biologics (NASDAQ:ABCL) founder and CEO, Carl Hansen, Ph.D., won the 2021 Bloom Burton Award, which honors an individual scientist, inventor, executive, entrepreneur, industry leader, or policy maker who made...

October 1, 2021

Tag - ABCL

Confo, AbCellera in GPCR-targeting antibody discovery program

AbCellera Biologics CEO Carl Hansen wins 2021 Bloom Burton Award

General

More